Cornerstone Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,693
Closed -$213K 1292
2018
Q3
$213K Buy
1,693
+903
+114% +$114K ﹤0.01% 1171
2018
Q2
$213K Buy
+790
New +$213K ﹤0.01% 1303